BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36514789)

  • 1. Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells.
    Corey D; Haeseleer F; Hou J; Corey L
    Mol Ther Methods Clin Dev; 2023 Mar; 28():1-10. PubMed ID: 36514789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. African green monkey TRIM5α restriction in simian immunodeficiency virus-specific rhesus macaque effector CD4 T cells enhances their survival and antiviral function.
    Jain S; Trivett MT; Ayala VI; Ohlen C; Ott DE
    J Virol; 2015 Apr; 89(8):4449-56. PubMed ID: 25653448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.
    Fujita T; Burwitz BJ; Chew GM; Reed JS; Pathak R; Seger E; Clayton KL; Rini JM; Ostrowski MA; Ishii N; Kuroda MJ; Hansen SG; Sacha JB; Ndhlovu LC
    J Immunol; 2014 Dec; 193(11):5576-83. PubMed ID: 25348621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
    Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
    Front Immunol; 2018; 9():492. PubMed ID: 29616024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.
    Rainho JN; Martins MA; Cunyat F; Watkins IT; Watkins DI; Stevenson M
    J Virol; 2015 Oct; 89(20):10625-36. PubMed ID: 26269172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation.
    Cieniewicz B; Bhatta A; Torabi D; Baichoo P; Saxton M; Arballo A; Nguyen L; Thomas S; Kethar H; Kukutla P; Shoaga O; Yu B; Yang Z; Fate M; Oliveira E; Ning H; Corey L; Corey D
    Mol Ther; 2023 Jul; 31(7):2132-2153. PubMed ID: 37194236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of protein kinases dysregulated in CD4(+) T cells in pathogenic versus apathogenic simian immunodeficiency virus infection.
    Bostik P; Wu P; Dodd GL; Villinger F; Mayne AE; Bostik V; Grimm BD; Robinson D; Kung HJ; Ansari AA
    J Virol; 2001 Dec; 75(23):11298-306. PubMed ID: 11689610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Tim-3 on T cells during acute simian immunodeficiency virus infection and on antigen specific responders.
    Amancha PK; Hong JJ; Ansari AA; Villinger F
    AIDS; 2015 Mar; 29(5):531-6. PubMed ID: 25715103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env.
    Braun SE; Lu XV; Wong FE; Connole M; Qiu G; Chen Z; Slepushkina T; Slepushkin V; Humeau LM; Dropulic B; Johnson RP
    Hum Gene Ther; 2007 Jul; 18(7):653-64. PubMed ID: 17600461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection.
    Bostik P; Dodd GL; Villinger F; Mayne AE; Ansari AA
    J Virol; 2004 Feb; 78(3):1464-72. PubMed ID: 14722302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques.
    Cartwright EK; Palesch D; Mavigner M; Paiardini M; Chahroudi A; Silvestri G
    J Virol; 2016 Aug; 90(15):6699-6708. PubMed ID: 27170752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.
    Mendoza D; Migueles SA; Rood JE; Peterson B; Johnson S; Doria-Rose N; Schneider D; Rakasz E; Trivett MT; Trubey CM; Coalter V; Hallahan CW; Watkins D; Franchini G; Lifson JD; Connors M
    PLoS Pathog; 2013 Feb; 9(2):e1003195. PubMed ID: 23468632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
    Chackerian B; Haigwood NL; Overbaugh J
    Virology; 1995 Nov; 213(2):386-94. PubMed ID: 7491763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques.
    Haeseleer F; Fukazawa Y; Park H; Varco-Merth B; Rust BJ; Smedley JV; Eichholz K; Peterson CW; Mason R; Kiem HP; Roederer M; Picker LJ; Okoye AA; Corey L
    Mol Ther Methods Clin Dev; 2021 Sep; 22():304-319. PubMed ID: 34485613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection.
    Meythaler M; Martinot A; Wang Z; Pryputniewicz S; Kasheta M; Ling B; Marx PA; O'Neil S; Kaur A
    J Virol; 2009 Jan; 83(2):572-83. PubMed ID: 18987149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques.
    Mavigner M; Habib J; Deleage C; Rosen E; Mattingly C; Bricker K; Kashuba A; Amblard F; Schinazi RF; Lawson B; Vanderford TH; Jean S; Cohen J; McGary C; Paiardini M; Wood MP; Sodora DL; Silvestri G; Estes J; Chahroudi A
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.
    Avalos CR; Price SL; Forsyth ER; Pin JN; Shirk EN; Bullock BT; Queen SE; Li M; Gellerup D; O'Connor SL; Zink MC; Mankowski JL; Gama L; Clements JE
    J Virol; 2016 Jun; 90(12):5643-5656. PubMed ID: 27030272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
    Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.